drugset / Trial / NCT00370747

Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

NCT00370747

Phase 2 Completed 162 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome

Timeline

Start
2006-09
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecabet Small molecule 2.83 % Other
Subject Ecabet Small molecule 3.7 % Other

Indications